Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.
about
Differential diagnostics of pain in the course of trigeminal neuralgia and temporomandibular joint dysfunction.RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine.
P2860
Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@en
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@nl
type
label
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@en
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@nl
prefLabel
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@en
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@nl
P2860
P356
P1476
Improving therapeutic ratio in ...... nd cisplatin-based treatments.
@en
P2093
Loredana G Marcu
P2860
P304
P356
10.1155/2013/817279
P407
P577
2013-12-19T00:00:00Z